143 related articles for article (PubMed ID: 19505923)
1. Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis.
Sood AK; Wang J; Mhawech-Fauceglia P; Jana B; Liang P; Geradts J
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1899-903. PubMed ID: 19505923
[TBL] [Abstract][Full Text] [Related]
2. The ets-domain transcription factor Spdef promotes maturation of goblet and paneth cells in the intestinal epithelium.
Gregorieff A; Stange DE; Kujala P; Begthel H; van den Born M; Korving J; Peters PJ; Clevers H
Gastroenterology; 2009 Oct; 137(4):1333-45.e1-3. PubMed ID: 19549527
[TBL] [Abstract][Full Text] [Related]
3. Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer.
Turner DP; Moussa O; Sauane M; Fisher PB; Watson DK
Cancer Res; 2007 Feb; 67(4):1618-25. PubMed ID: 17308102
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex.
Cho JY; Lee M; Ahn JM; Park ES; Cho JH; Lee SJ; Kim BG; Heo SH; Park HJ; Zerbini LF; Hwang D; Libermann TA
J Proteome Res; 2009 Mar; 8(3):1327-37. PubMed ID: 19203193
[TBL] [Abstract][Full Text] [Related]
5. Enhanced motility of KGF-transfected breast cancer cells.
Zang XP; Bullen EC; Manjeshwar S; Jupe ER; Howard EW; Pento JT
Anticancer Res; 2006; 26(2A):961-6. PubMed ID: 16619493
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of an Ets protein, PEA3, in breast cancer cell lines MDA-MB-361DYT2 and BT474M1.
Yu Z; Xia W; Wang HY; Wang SC; Pan Y; Kwong KY; Hortobagyi GN; Hung MC
Mol Carcinog; 2006 Sep; 45(9):667-75. PubMed ID: 16652376
[TBL] [Abstract][Full Text] [Related]
8. Prostate-derived Ets factor, an oncogenic driver in breast cancer.
Sood AK; Geradts J; Young J
Tumour Biol; 2017 May; 39(5):1010428317691688. PubMed ID: 28468594
[TBL] [Abstract][Full Text] [Related]
9. Lineage infidelity and expression of melanocytic markers in human breast cancer.
Bachmeier BE; Nerlich AG; Mirisola V; Jochum M; Pfeffer U
Int J Oncol; 2008 Nov; 33(5):1011-5. PubMed ID: 18949364
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells.
Singh B; Cook KR; Vincent L; Hall CS; Berry JA; Multani AS; Lucci A
J Surg Res; 2008 Jun; 147(2):240-6. PubMed ID: 18498876
[TBL] [Abstract][Full Text] [Related]
11. Growth suppression of MCF-7 cancer cell-derived xenografts in nude mice by caveolin-1.
Wu P; Wang X; Li F; Qi B; Zhu H; Liu S; Cui Y; Chen J
Biochem Biophys Res Commun; 2008 Nov; 376(1):215-20. PubMed ID: 18778685
[TBL] [Abstract][Full Text] [Related]
12. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
Steffan JJ; Koul HK
Cancer Lett; 2011 Nov; 310(1):109-17. PubMed ID: 21764212
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of basal-like subtype in triple-negative breast cancer.
Yamamoto Y; Ibusuki M; Nakano M; Kawasoe T; Hiki R; Iwase H
Breast Cancer; 2009; 16(4):260-7. PubMed ID: 19701681
[TBL] [Abstract][Full Text] [Related]
14. Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo.
Akiri G; Sabo E; Dafni H; Vadasz Z; Kartvelishvily Y; Gan N; Kessler O; Cohen T; Resnick M; Neeman M; Neufeld G
Cancer Res; 2003 Apr; 63(7):1657-66. PubMed ID: 12670920
[TBL] [Abstract][Full Text] [Related]
15. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
[TBL] [Abstract][Full Text] [Related]
16. Ets-1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment.
Furlan A; Vercamer C; Desbiens X; Pourtier A
J Cell Physiol; 2008 Jun; 215(3):782-93. PubMed ID: 18181172
[TBL] [Abstract][Full Text] [Related]
17. SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer.
Cheng CJ; Lin YC; Tsai MT; Chen CS; Hsieh MC; Chen CL; Yang RB
Cancer Res; 2009 Apr; 69(8):3634-41. PubMed ID: 19369267
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cells.
Gomes EM; Rodrigues MS; Phadke AP; Butcher LD; Starling C; Chen S; Chang D; Hernandez-Alcoceba R; Newman JT; Stone MJ; Tong AW
Clin Cancer Res; 2009 Feb; 15(4):1317-25. PubMed ID: 19228733
[TBL] [Abstract][Full Text] [Related]
19. E1AF promotes breast cancer cell cycle progression via upregulation of Cyclin D3 transcription.
Jiang J; Wei Y; Liu D; Zhou J; Shen J; Chen X; Zhang S; Kong X; Gu J
Biochem Biophys Res Commun; 2007 Jun; 358(1):53-8. PubMed ID: 17467662
[TBL] [Abstract][Full Text] [Related]
20. SPDEF is overexpressed in gastric cancer and triggers cell proliferation by forming a positive regulation loop with FoxM1.
Wu J; Qin W; Wang Y; Sadik A; Liu J; Wang Y; Song P; Wang X; Sun K; Zeng J; Wang L
J Cell Biochem; 2018 Nov; 119(11):9042-9054. PubMed ID: 30076647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]